This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2009 Oct;24(10):2970-2.

doi: 10.1093/ndt/gfp366. Epub 2009 Jul 24.

Sevelamer versus calcium-based phosphate binders in chronic kidney disease: what should we conclude from the evidence to date?

David W Johnson

PMID: 19633092
DOI: 10.1093/ndt/gfp366

Editorial

Sevelamer versus calcium-based phosphate binders in chronic kidney disease: what should we conclude from the evidence to date?

David W Johnson. Nephrol Dial Transplant. 2009 Oct.

. 2009 Oct;24(10):2970-2.

doi: 10.1093/ndt/gfp366. Epub 2009 Jul 24.

Author

David W Johnson

PMID: 19633092
DOI: 10.1093/ndt/gfp366

No abstract available

PubMed Disclaimer

Comment on

The effects of calcium-based versus non-calcium-based phosphate binders on mortality among patients with chronic kidney disease: a meta-analysis.
Jamal SA, Fitchett D, Lok CE, Mendelssohn DC, Tsuyuki RT. Jamal SA, et al. Nephrol Dial Transplant. 2009 Oct;24(10):3168-74. doi: 10.1093/ndt/gfp350. Epub 2009 Jul 21. Nephrol Dial Transplant. 2009. PMID: 19622572

Similar articles

Sevelamer: a promising but unproven drug.
Palmer SC, Craig JC, Strippoli GF. Palmer SC, et al. Nephrol Dial Transplant. 2007 Oct;22(10):2742-5. doi: 10.1093/ndt/gfm561. Nephrol Dial Transplant. 2007. PMID: 17906325 No abstract available.
[Phosphate binders in chronic kidney disease: the positions of sevelamer].
Fomin VV, Shilov EM, Svistunov AA, Milovanov IuS. Fomin VV, et al. Ter Arkh. 2013;85(6):96-9. Ter Arkh. 2013. PMID: 23875200 Review. Russian.
Oral phosphate binders in patients with kidney failure.
Tonelli M, Pannu N, Manns B. Tonelli M, et al. N Engl J Med. 2010 Apr 8;362(14):1312-24. doi: 10.1056/NEJMra0912522. N Engl J Med. 2010. PMID: 20375408 Review. No abstract available.
After several years of witchhunting, can calcium-based phosphate binding be released on probation?
Ketteler M, Biggar P. Ketteler M, et al. Nephrol Dial Transplant. 2008 Jan;23(1):17-9. doi: 10.1093/ndt/gfm801. Epub 2007 Nov 26. Nephrol Dial Transplant. 2008. PMID: 18039641 No abstract available.
[Clinical aspect of recent progress in phosphate metabolism. Phosphate retension, a powerful risk factor for mortality in chronic kidney disease (CKD)].
Imanishi Y. Imanishi Y. Clin Calcium. 2009 Jun;19(6):828-35. Clin Calcium. 2009. PMID: 19483278 Review. Japanese.

See all similar articles

Cited by

Pharmacology, efficacy and safety of oral phosphate binders.
Hutchison AJ, Smith CP, Brenchley PE. Hutchison AJ, et al. Nat Rev Nephrol. 2011 Sep 6;7(10):578-89. doi: 10.1038/nrneph.2011.112. Nat Rev Nephrol. 2011. PMID: 21894188 Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information